EP2281831 - Bibliographic data
Vaccin de virus de Varicelle Zoster
| Last update | 31/05/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Européen |
| (73) Holder |
GlaxoSmithKline Biologicals S.A. Rue de l'Institut, 89
1330 Rixensart
Belgique
|
|---|---|
| (72) Inventors |
Emmanuel Jules Hanon GlaxoSmithKline Biologicals S.A.
Rue de l'Institut 89
1330 Rixensart
Belgique
Jean Stephenne GlaxoSmithKline Biologicals S.A.
Rue de l'Institut 89
1330 Rixensart
Belgique
|
| (74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP10188256.1 |
|---|---|
| (22) Request date | 01/03/2006 |
| (11) Publication number | EP2281831 |
|---|---|
| Publication date | 18/04/2018 |
| (54) Title of the invention | Vaccin de virus de Varicelle Zoster |
|---|---|
| (51) International classification | C07K 14/04, A61K 39/25, A61K 39/39, A61P 31/22 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 0504436 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | None |
|---|---|
| Last annuity | Annuity: 20 - Payment date 28/02/2025 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 18/04/2018 Constitution de mandataire pour un dossier - Legal date 13/06/2018 |